SelectedWorks - Mohamed Alsharedi

Contact

Selected Works of Mohamed Alsharedi

Assistant Professor, Marshall University Joan C. Edwards School of Medicine

Mohamed F. Alsharedi, M.D, FACP
Assistant Professor of Medicine/ Section of Hematology and Medical oncology 
Marshall University Joan C. Edwards School of Medicine and the Edwards Comprehensive Cancer Center.  

Works
About

×

About Mohamed Alsharedi

Mohamed F. Alsharedi, M.D, FACP
Assistant Professor of Medicine/ Section of Hematology and Medical oncology 
Marshall University Joan C. Edwards School of Medicine and the Edwards Comprehensive Cancer Center.  

Present	Assistant Professor, Marshall University
Institution Organization Position Type Position Title Time Period to Options Current Position Affiliate my profile with this Institution

Medicine and Health Sciences, Hematology, and Oncology

Solid Tumors & Malignant Hematology

Leukemia cutis in a patient with chronic lymphocytic leukemia presenting ...

SAGE Open Medical Case Reports (2016)

Mohamed Alsharedi

Chronic lymphocytic leukemia, the most common adult leukemia worldwide, is considered an indolent but incurable non-Hodgkin lymphoma. Leukemia cutis is ...

Primary Retroperitoneal Melanoma Presented in a Rare Extracutaneous Site for ...

Rare Tumors (2016)

Mohamed Alsharedi

Malignant melanoma, as the name implies, is a malignant tumor of melanocytes, found in the skin, eyes, meningeal lining and ...

Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

BMJ Case Reports (2016)

Mohamed Alsharedi

Recent advances in novel immunotherapeutic and targeted therapeutic agents have increased treatment options in patients with advanced metastatic melanoma. However, ...

Metastatic Sarcomatoid Carcinoma of the Small Intestine: a Case Report ...

Journal of Gastrointestinal Cancer (2015)

Mohamed Alsharedi

Comparison of toxicity profile and tolerability between two standard of ...

Medical Oncology (2016)

Mohamed Alsharedi

In breast cancer, there are two widely used paclitaxel-based adjuvant chemotherapies, either dose dense paclitaxel (ddP) or weekly paclitaxel (wP). ...

Delaying Chemotherapy in the Treatment of Stage IV Non-Small Cell ...

Biochemistry and Microbiology (2016)

Mohammad Mozayen, Mohamed Alsharedi, Inderjit Mehmi, Todd W. Gress, et al.

Background: Whether a delay in the initiation of chemotherapy for advanced non-small cell lung cancer (NSCLC) can affect overall survival ...

Pancreatic cancer survival in elderly patients treated with chemotherapy.

Pancreas (2014)

Mohamed Alsharedi

OBJECTIVES: Pancreatic cancer is a lethal disease mostly affecting elderly people. Clinical trials on treatment contain disproportionately fewer elderly patients ...

review article (2)

No TitleDurvalumab for the treatment of urothelial carcinoma.

Drugs Today (2017)

Mohamed Alsharedi

Immunotherapy has revolutionized cancer care in the modern era of oncology. Research in immunotherapy has led to important advances in ...

Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma

BMJ Case Reports (2016)

Mohamed Alsharedi

Recent advances in novel immunotherapeutic and targeted therapeutic agents have increased treatment options in patients with advanced metastatic melanoma. However, ...